Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

被引：0
|
作者：
Carmen M. Labandeira
Maria G. Alonso Losada
Rosa Yáñez Baña
Maria I. Cimas Hernando
Iria Cabo López
Jose M. Paz González
Maria J. Gonzalez Palmás
Cristina Martínez Miró
Diego Santos García
机构：
[1] CHUVI,Department of Clinical Neurology
[2] Complejo Hospitalario Universitario de Vigo,undefined
[3] CHUO,undefined
[4] Complejo Hospitalario Universitario de Ourense,undefined
[5] Hospital de Povisa,undefined
[6] CHOP,undefined
[7] Complejo Hospitalario Universitario de Pontevedra,undefined
[8] CHUAC,undefined
[9] Complejo Hospitalario Universitario de A Coruña,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Safinamide; Non-motor symptoms; Parkinson’s disease; Depression; Mood;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5398 / 5411
页数：13
相关论文
共 50 条
  • [41] Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study
    Pena, Esteban
    Borrue, Carmen
    Mata, Marina
    Carlos Martinez-Castrillo, Juan
    Alonso-Canovas, Araceli
    Luis Chico, Juan
    Lopez-Manzanares, Lydia
    Llanero, Marcos
    Herreros-Rodriguez, Jaime
    Esquivel, Alberto
    Maycas-Cepeda, Teresa
    Ruiz-Huete, Cristina
    BRAIN SCIENCES, 2021, 11 (02) : 1 - 11
  • [42] Pilates method improves balance control in Parkinson's disease patients: An open-label clinical trial
    Maciel, David Pereira
    Mesquita, Vivia Linhares
    Marinho, Antonia Rosivalda
    Ferreira, Glauber Menezes
    Abdon, Ana Paula
    Martins, Fernanda
    PARKINSONISM & RELATED DISORDERS, 2020, 77 : 18 - 19
  • [43] Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording
    Calandra-Buonaura, Giovanna
    Guaraldi, Pietro
    Doria, Andrea
    Zanigni, Stefano
    Nassetti, Stefania
    Favoni, Valentina
    Cevoli, Sabina
    Provini, Federica
    Cortelli, Pietro
    PARKINSONS DISEASE, 2016, 2016
  • [44] A meta-analysis of the effectiveness and safety of safinamide for levodopa-induced motor complications in Parkinson's disease
    Li, Jiaojiao
    Zhang, Jianyu
    Meng, Pin
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (04) : 4627 - 4638
  • [45] Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study
    Horisawa, Shiro
    Fukui, Atsushi
    Yamahata, Hayato
    Tanaka, Yukiko
    Kuwano, Atsushi
    Momosaki, Oji
    Iijima, Mutsumi
    Nanke, Magi
    Kawamata, Takakazu
    Taira, Takaomi
    JOURNAL OF NEUROSURGERY, 2021, 135 (03) : 799 - 805
  • [46] Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study
    Bianchini, Edoardo
    Sforza, Michela
    Rinaldi, Domiziana
    Alborghetti, Marika
    De Carolis, Lanfranco
    Della Gatta, Francesco
    Pontieri, Francesco E.
    NEUROLOGICAL RESEARCH, 2021, 43 (11) : 950 - 954
  • [47] Tolcapone in elderly patients with Parkinson's disease: A prospective open-label multicenter non-interventional trial
    Ebersbach, Georg
    Storch, Alexander
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 49 (01) : E40 - E44
  • [48] Conversion from dopamine agonists to pramipexoleAn open-label trial in 227 patients with advanced Parkinson’s disease
    G. Linazasoro
    Journal of Neurology, 2004, 251 : 335 - 339
  • [49] Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)
    Litvinenko, In.
    Odinak, M. M.
    Mogilnaya, V. I.
    Emelin, A. Yu.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2007, 107 (12): : 25 - 33
  • [50] Conversion from dopamine agonists to pramipexole - An open-label trial in 227 patients with advanced Parkinson's disease
    Linazasoro, G
    JOURNAL OF NEUROLOGY, 2004, 251 (03) : 335 - 339
12345